Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

2.80
-0.1600-5.41%
Post-market: 2.800.00000.00%16:05 EDT
Volume:454.56K
Turnover:1.30M
Market Cap:239.47M
PE:-1.40
High:2.95
Open:2.91
Low:2.79
Close:2.96
Loading ...

Radoff Bradley Louis - Purchased Atea Pharmaceuticals' Shares Based Belief That the Shares, When Purchased, Were Undervalued

THOMSON REUTERS
·
04 Mar

Radoff Bradley Louis Reports 3.3% Stake in Atea Pharmaceuticals as of Feb 27 - SEC Filing

THOMSON REUTERS
·
04 Mar

Radoff Bradley Louis - Intend to Nominate a Competing Slate of Candidates for Election to Atea Pharmaceuticals' Board at Upcoming Annual Meeting

THOMSON REUTERS
·
04 Mar

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025

GlobeNewswire
·
27 Feb

Atea Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
25 Feb

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

THOMSON REUTERS
·
24 Feb

Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

GlobeNewswire
·
24 Feb

Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43Rd Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS
·
13 Jan

Atea Pharmaceuticals Inc: Cash Runway Anticipated Into 2028

THOMSON REUTERS
·
13 Jan

Atea Pharmaceuticals Inc - Reports Cash Balance of $454.7 Million at Dec 31, 2024

THOMSON REUTERS
·
13 Jan

Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
13 Jan

BRIEF-Bradley L. Radoff And Michael Torok Calls For Atea Pharmaceuticals To Appoint New, Lead Independent Director To Oversee Strategic Review Process

Reuters
·
19 Dec 2024

Bradley L. Radoff and Michael Torok: Collectively Own About 3% of Outstanding Shares of Atea Pharmaceuticals

THOMSON REUTERS
·
19 Dec 2024

Bradley L. Radoff and Michael Torok: Calls for Atea Pharmaceuticals to Appoint New, Lead Independent Director to Oversee Strategic Review Process

THOMSON REUTERS
·
19 Dec 2024

Atea Pharmaceuticals retains financial advisor to explore partnerships

TIPRANKS
·
16 Dec 2024

Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships

THOMSON REUTERS
·
16 Dec 2024

Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships

GlobeNewswire
·
16 Dec 2024

After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study

Benzinga
·
05 Dec 2024

BUZZ-Atea Pharma rises as combo drug meets main goal in mid-stage study

Reuters
·
04 Dec 2024

Atea Pharmaceuticals announces results from Phase 2 regimen of bemnifosbuvir

TIPRANKS
·
04 Dec 2024